1. Home
  2. CINT vs CADL Comparison

CINT vs CADL Comparison

Compare CINT & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CI&T Inc

CINT

CI&T Inc

HOLD

Current Price

$3.38

Market Cap

478.1M

Sector

Technology

ML Signal

HOLD

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$7.95

Market Cap

578.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CINT
CADL
Founded
1995
1999
Country
Brazil
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
478.1M
578.8M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
CINT
CADL
Price
$3.38
$7.95
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
7
Target Price
$7.35
$19.00
AVG Volume (30 Days)
99.0K
2.1M
Earning Date
05-11-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
58.62
EPS
N/A
N/A
Revenue
N/A
$125,000.00
Revenue This Year
$16.69
N/A
Revenue Next Year
$11.28
N/A
P/E Ratio
$17.94
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.51
$4.35
52 Week High
$6.31
$9.27

Technical Indicators

Market Signals
Indicator
CINT
CADL
Relative Strength Index (RSI) 27.21 58.29
Support Level N/A $4.91
Resistance Level $5.01 $9.27
Average True Range (ATR) 0.22 0.65
MACD -0.02 -0.12
Stochastic Oscillator 3.85 30.53

Price Performance

Historical Comparison
CINT
CADL

About CINT CI&T Inc

CI&T Inc operates as a partner in tech-integrated business solutions, helping organizations address complex challenges by integrating business approach, technology, and artificial intelligence into a single, coherent operating model. It is mainly engaged in the development of customizable software through the implementation of software solutions, including machine learning, artificial intelligence, data analytics, cloud migration and mobility technologies. The company provides technology services to various industry verticals, including Financial Services, Consumer Goods, Technology and Communications, Retail and Industrial Goods, Life Sciences, among others. The majority of the revenue is derived from providing technology services. Geographically, maximum revenue is derived from Brazil.

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Share on Social Networks: